Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy ARQT Stock  Free ARQT Stock Alerts

Arcutis Biotherapeutics (ARQT) Insider Trading & Ownership

Arcutis Biotherapeutics logo
$15.24 +0.59 (+4.03%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$15.52 +0.28 (+1.84%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7,771.23
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$2.45 M
Get ARQT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcutis Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARQT Insider Buying and Selling by Quarter

Arcutis Biotherapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/24/2025Todd Franklin WatanabeInsiderSell1,500$17.52$26,280.00  
3/17/2025Todd Franklin WatanabeInsiderSell1,200$17.61$21,132.00  
3/14/2025Patrick BurnettInsiderSell12,242$15.04$184,119.68  
3/3/2025Howard G WelgusDirectorSell10,000$13.00$130,000.00  
3/3/2025Patrick BurnettInsiderSell2,819$13.03$36,731.57  
2/3/2025Howard G WelgusDirectorSell10,000$12.71$127,100.00  
2/3/2025Masaru MatsudaInsiderSell8,338$12.70$105,892.60  
1/2/2025Howard G WelgusDirectorSell10,000$14.67$146,700.00  
12/31/2024Patrick BurnettInsiderSell1,691$14.00$23,674.00  
12/20/2024Todd Franklin WatanabeInsiderSell15,000$15.17$227,550.00  
12/2/2024Howard G WelgusDirectorSell10,000$12.51$125,100.00  
11/30/2024Larry Todd EdwardsInsiderBuy1,093$7.11$7,771.23  
11/22/2024Patrick BurnettInsiderSell16,023$10.14$162,473.22  
11/19/2024Masaru MatsudaInsiderSell1,775$9.68$17,182.00  
11/15/2024Patrick BurnettInsiderSell100$10.03$1,003.00  
11/11/2024Terrie CurranDirectorSell8,687$10.85$94,253.95  
11/4/2024Masaru MatsudaInsiderSell5,015$8.68$43,530.20  
11/1/2024Howard G WelgusDirectorSell10,000$8.65$86,500.00  
10/2/2024Larry Todd EdwardsSVPSell3,725$10.01$37,287.25  
10/1/2024Howard G WelgusDirectorSell10,000$9.26$92,600.00  
9/24/2024David Joseph TopperCFOSell11,626$9.48$110,214.48  
9/3/2024Howard G WelgusDirectorSell10,000$10.77$107,700.00  
8/19/2024Patrick BurnettInsiderSell1,728$8.29$14,325.12  
8/2/2024Masaru MatsudaInsiderSell5,220$9.02$47,084.40  
8/1/2024Howard G WelgusDirectorSell10,000$9.87$98,700.00  
7/1/2024Howard G WelgusDirectorSell10,000$9.31$93,100.00  
5/30/2024Patrick BurnettInsiderSell23,000$8.75$201,250.00  
5/28/2024Masaru MatsudaInsiderSell1,775$9.01$15,992.75  
5/17/2024Larry Todd EdwardsSVPSell7,640$8.98$68,607.20  
(Data available from 1/1/2013 forward)

ARQT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Arcutis Biotherapeutics includes David Joseph Topper, David W Osborne, Howard G Welgus, Larry Todd Edwards, Life Sciences Viii L Frazier, Masaru Matsuda, Orbimed Advisors Llc, Patricia A Turney, Patrick Burnett, Scott L Burrows, Terrie Curran, and Todd Franklin Watanabe. Learn more on insiders at ARQT.

9.50% of Arcutis Biotherapeutics stock is owned by insiders. Learn more on ARQT's insider holdings.

The following insiders have purchased ARQT shares in the last 24 months: Larry Todd Edwards ($7,771.23), and Life Sciences Viii L Frazier ($200,000.00).

Insiders have purchased a total of 81,093 ARQT shares in the last 24 months for a total of $207,771.23 bought.

The following insiders have sold ARQT shares in the last 24 months: David Joseph Topper ($110,214.48), Howard G Welgus ($1,007,500.00), Larry Todd Edwards ($105,894.45), Masaru Matsuda ($289,430.15), Patrick Burnett ($639,566.29), Terrie Curran ($94,253.95), and Todd Franklin Watanabe ($274,962.00).

Insiders have sold a total of 229,474 Arcutis Biotherapeutics shares in the last 24 months for a total of $2,521,821.32 sold.

Arcutis Biotherapeutics Key Executives


Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:ARQT) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored